Fundraising Fox

Cardiodx

Redwood City, US · Delaware corporation

Biotech

Founders & leadership

MM
Mark MonaneExecutive
GR
Gwen R. CarscaddenExecutive
DL
David L. LevisonExecutive
BH
Brook H. ByersNamed on SEC filing
DL
Deborah L. KilpatrickNamed on SEC filing
RF
Robert F. WernerNamed on SEC filing
DT
Douglas T. RossNamed on SEC filing
MG
Melinda GriffithNamed on SEC filing

Board

PG
Patrick G. EnrightBoard director
LL
Louis LangeBoard director
AS
Ajit SinghBoard director
HH
Hongjie HuBoard director

Reported raises · per SEC filings

Form D private placements

$51.5M disclosed across 3 rounds · 2014–2017

▶$18.1MraisedJan 2017 · 7 investors · Biotechnology
Rule 506(b)
Officers, directors & promoters on the filing
  • Hongjie HuDirector
  • Mark MonaneExecutive Officer
  • Patrick G. EnrightDirector
  • Ajit SinghDirector
  • David L. LevisonDirector
  • Tim HennExecutive Officer
  • Khushro F. MehtaExecutive Officer, Director
  • Susan DanielsExecutive Officer
  • Jim WingroveExecutive Officer
  • Duane WilliamsExecutive Officer
Offering amount
$41.8M
Amount sold
$18.1M
First sale
Jan 2017
Incorporated
Corporation, Delaware
Federal exemptions
06b
Full filing on SEC EDGAR ↗
▶$12.4MraisedFeb 2016 · 15 investors · Biotechnology
Rule 506(b)
Officers, directors & promoters on the filing
  • Mark MonaneExecutive Officer
  • Patrick G. EnrightDirector
  • Gwen R. CarscaddenExecutive Officer
  • Louis LangeDirector
  • Andrew L. GuggenhimeDirector
  • James R. TobinDirector
  • David L. LevisonExecutive Officer, Director
  • Ajit SinghDirector
  • Hongjie HuDirector
Offering amount
$25.5M
Amount sold
$12.4M
First sale
Jun 2015
Incorporated
Corporation, Delaware
Federal exemptions
06b
Full filing on SEC EDGAR ↗
▶$21MraisedJul 2014 · 14 investors · Biotechnology
Rule 506(c)
Officers, directors & promoters on the filing
  • Patrick G. EnrightDirector
  • David L. LevisonExecutive Officer, Director
  • Mark MonaneExecutive Officer
  • Brook H. ByersDirector
  • Deborah L. KilpatrickExecutive Officer
  • Robert F. WernerExecutive Officer
  • Andrew L. GuggenhimeDirector
  • Douglas T. RossExecutive Officer
  • Melinda GriffithExecutive Officer
  • Ajit SinghDirector
  • Gwen R. CarscaddenExecutive Officer
  • Louis LangeDirector
  • James R. TobinDirector
Offering amount
$25M
Amount sold
$21M
First sale
Jul 2014
Incorporated
Corporation, Delaware
Federal exemptions
06c
Full filing on SEC EDGAR ↗

Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.

Frequently asked questions

How much funding has Cardiodx raised?
Cardiodx has disclosed $51.5M raised across 3 rounds.
Where is Cardiodx headquartered?
Cardiodx is headquartered in Redwood City, US.